BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced two poster presentations ...
The Boston Globe’s most recent circulation numbers show it is now down more than 50% since the last year before the pandemic, ...
SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations ...
The plant closings are part of an ongoing series of shutdowns that Quad executives say are part of a strategy to align the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback